EUVIMEDEUVIMED entdecken
Crossref

Targeted Therapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer—Patient Selection Changes the Fate of Gefitinib

Susanne Rogers and Imogen Locke

Clinical Medicine Reviews in Oncology · 2010

DOI: 10.4137/cmro.s3276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Medicine Reviews in Oncology, 2010. Verfasst von Susanne Rogers and Imogen Locke.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Locke, S. R. A. I. (2010). Targeted Therapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer—Patient Selection Changes the Fate of Gefitinib. Clinical Medicine Reviews in Oncology. https://doi.org/10.4137/cmro.s3276

Vancouver

Locke SRAI. Targeted Therapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer—Patient Selection Changes the Fate of Gefitinib. Clinical Medicine Reviews in Oncology. 2010. doi:10.4137/cmro.s3276

BibTeX
@article{Locke2010,
  author = {Locke, Susanne Rogers and Imogen},
  title = {Targeted Therapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer—Patient Selection Changes the Fate of Gefitinib},
  journal = {Clinical Medicine Reviews in Oncology},
  year = {2010},
  doi = {10.4137/cmro.s3276}
}
Kostenlos starten →